Carregant...

RAS mutations predict radiologic and pathologic response in patients treated with chemotherapy prior to resection of colorectal liver metastases

PURPOSE: RAS mutations have been reported to be a potential prognostic factor in patients with colorectal liver metastases (CLM). However, the impact of RAS mutations on response to chemotherapy remains unclear. We sought to determine the association between RAS mutations and response to preoperativ...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Surg Oncol
Autors principals: Zimmitti, Giuseppe, Shindoh, Junichi, Mise, Yoshihiro, Kopetz, Scott, Loyer, Evelyne M., Andreou, Andreas, Cooper, Amanda B., Kaur, Harmeet, Aloia, Thomas A., Maru, Dipen M., Vauthey, Jean-Nicolas
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4318708/
https://ncbi.nlm.nih.gov/pubmed/25227306
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-014-4042-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!